, /PRNewswire/ -- . , a healthcare innovation campus in , today unveiled results from at the in Cure conducted this highly anticipated assessment of the biotech industry in partnership with the , a division of Deerfield Management Company. The stakeholders surveyed included company founders and CEOs, managing directors, investors, scientists, and more.
"The data and insights captured in exemplifies Cure's mission to provide need-to-know and actionable information for innovators and entrepreneurs advancing healthcare. We found an overwhelming sense of hope and optimism across the sector, and a consensus for more investment in women's health, which should be a key lever to drive growth the growth that 79 percent of respondents predict. Surprisingly, the Inflation Reduction Act was not largely seen as a key influencer, even with the near equal ranking of policy and technologies as disrupters," said .
. . The state of women's health research and treatment is capturing increased attention in science and society.
. Kumar continued: "The strong optimism documented in is encouraging and will fuel activities for Cure's ecosystem, including upcoming special initiatives and programming that will power fresh conversations, trigger innovation and spur new investments." Also, during BIO, Cure will host Fireside Chats daily at .
Please stop by Booth 4741 to meet the team and learn more. The full survey is available for download from Cure's digital content platform, – a go-to destination f.
